openPR Logo
Press release

curasan AG: Bioactive bone regeneration material approved for sale in Europe

10-22-2010 07:36 AM CET | Health & Medicine

Press release from: curasan AG

/ PR Agency: fr
Kleinostheim, Germany – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8) has received European approval for its new granular bone regeneration material Ceracell®.

Hans Dieter Rössler, CEO of curasan AG, considers the CE-certification of Ceracell® to be another milestone in the implementation of the product offensive launched at the beginning of the year: “We are implementing our strategy of offering innovative biomaterials, customized to the needs of the users, both consistently and persistently. The launch of Ceracell® in the dental market is planned to coincide with the world’s largest international dental exhibition in Cologne (IDS) at the end of March next year, and it will be launched approximately three months later in the orthopaedic market.”

Ceracell® is a synthetic, completely absorbable and bioactive bone regeneration material. Although the porosity compared to Cerasorb® has been increased considerably yet again, the material has greater mechanical stability. Thanks to the spongy structure designed after human bones and an optimised formulation an increased number of bone-forming cells dock on Ceracell®, which leads to accelerated and qualitatively better bone regeneration. Ceracell® is especially suitable when the body’s own healing potency needs to be reinforced by substances for bone growth such as PRP, BMP, bone marrow or stem cells.

Background information about curasan AG:
Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading firms in the field of regenerative medicine especially in bone and tissue regeneration. In addition to the synthetic Cerasorb® bone substitution and regeneration material, the company has developed a future-oriented product pipeline. The goal during the next few years is to have further medical products ready for market rollout via well-positioned contractual partners in various market segments.

curasan AG
Andrea Weidner
Lindigstrasse 4
63801 Kleinostheim
Germany
Tel. 06027/40 900 51
Fax 06027/40 900 39
andrea.weidner@curasan.de
www.curasan.de

fr financial relations gmbh
Jörn Gleisner
Gutleutstrasse 75
60329 Frankfurt/Main
Germany
Tel. +49 (0)69 95 90 83 20
Fax +49 (0)69 95 90 83 99
j.gleisner@finanical-relations.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release curasan AG: Bioactive bone regeneration material approved for sale in Europe here

News-ID: 148857 • Views:

More Releases from curasan AG

curasan AG: Dental Business Unit acquired as of June 1
Kleinostheim, Germany, June 6, 2013 – curasan AG, Germany, has acquired a large part of the “Oral Regenerative Medicine” division of Riemser Pharma GmbH, Germany, effective June 1, 2013. curasan AG now owns the marketing and distribution rights for the products covered by the contract and is assuming the sales structures, including the na-tional and international customer base. As a result of this change, curasan has immediate access to the dental market
curasan AG now sells bone regeneration material in injectable form
curasan AG now sells bone regeneration material in injectable form
Kleinostheim, 05.12.2012 – curasan AG, listed on the General Standard (ISIN: DE 000 549 453 8), has introduced its new bone regeneration material CERASORB® Ortho Paste to the German and European markets at the beginning of December. CERASORB® Ortho Paste is comprised of fine granules of the proven, fully resorbable, synthetic material CERASORB® M Ortho suspended in a hyaluronic acid hydrogel-matrix. The paste-like product has the advantage that it is
curasan AG commences operations in the European market with the appointment of a …
Kleinostheim, 15.02.2012 – curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8), created a new post on 1st February 2012 in relation to the active expansion of its European sales network in the fields of Orthopaedics and trauma surgery. Mr. Lee McCann BSc Business Administration (North West University of Applied Science, London, U.K.), will be operating as the organisation’s International Sales Director for Orthobiologics with immediate
curasan AG: Novel bone regeneration material approved for sale in Europe
Kleinostheim, Germany – curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received European approval for a novel synthetic bone regeneration material. Osseolive® is a bioactive, poly-crystalline calcium-alkali-phosphate ceramic, which has a stimulating effect on bone formation as well as on bone mineralisation. “With Osseolive® emerging from our well-stocked development pipeline, we now have an ideal extension to our tricalcium-phosphate

All 5 Releases


More Releases for Ceracell®

Ultimate Chemicals® Featured in Manufacturing Marvels® on The Fox Business Net …
MOORE, OK., Oct. 8, 2021/ -- Ultimate Chemicals® Inc., an integrated manufacturer and supplier of chemicals and related services, is pleased to announce it will be showcased in a broadcast of Manufacturing Marvels® scheduled to air on October 14, 2021 at approximately 9:30-9:44 p.m. EST on The Fox Business Network® (FBN). Ultimate Chemicals has created their products to help restore surfaces to their optimum surface capability. Non-destructive to the surfaces to
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA and Intelligent Enterprise to Manufacturing, Consumer Products, Higher education, and research, Industrial machinery and components, Life sciences and Automotive Industries Chicago, IL, June 10, 2020 – Sunera Technologies, Inc announced that it had joined the SAP® PartnerEdge® program as a Re-sell & Services partner, through which it will resell SAP solutions to midsize organizations in North America. Through this engagement, SuneraTech
Infosim® announces release of StableNet® 8.5
Würzburg/Austin/Singapore, July 15th, 2019 – Infosim®, the technology leader in automated Service Fulfillment and Service Assurance solutions, today announced the release of version 8.5 of its award-winning software suite StableNet® for Telco and Enterprise customers. StableNet® 8.5 provides a significant number of powerful new features and improvements, including: • New functionalities of the Discovery Module spanning across o Connectivity Discovery, o Rediscovery, and o XML Discovery • Root Cause AI (Machine Learning-based Root Cause Analysis extension) • StableNet® Health Management • Improved Script Jobs • Enhanced
Infosim® announces release of StableNet® 7.5
Würzburg/Austin/Singapore, October 26th, 2015 – Infosim®, the technology leader in automated Service Fulfillment and Service Assurance solutions, today announced the release of version 7.5 of its award-winning software suite StableNet® for Telco and Enterprise customers. StableNet® 7.5 provides a significant number of powerful new features, including: • Dynamic Rule Generation (DRG); a new and revolutionary Fault Management concept • REST interface supporting the new StableNet® iPhone (and upcoming Android) app • Highly customizable dashboard in both the
GRAMMY® Performers Receiving AnthroSpa Logic® Announced
CHICAGO, IL- February, 2011- The Performers at the 53rd Annual GRAMMY® Awards, who will receive AnthroSpa Logic®, a luxury, 100% natural spa skin care and body care line inspired by the science of anthropology have been announced. The unique skin care line combines beauty secrets from around world and will be included in the in the Official VIP “Gift Bag” for the event, which takes place on Feb. 13,
American Megatrends Announces AMIBIOS®8 & Aptio®4.x Support for the Intel® Xe …
ATLANTA, GEORGIA - American Megatrends (AMI) is pleased to announce that its AMIBIOS®8 & Aptio®4.x products feature support for the new Intel® Xeon® 5500 Platform. The Intel® Xeon® 5500 platform combines the Intel® Xeon® Processor 5500 Series with the Intel® 5520 Chipset for embedded, storage, security and communications infrastructure applications in a wide range of form factors. There are four different processor options for this platform with seven year lifecycle support